Reduced susceptibility to vancomycin in isogenic Staphylococcus aureus strains of sequence type 59: tracking evolution and identifying mutations by whole-genome sequencing

Contribution of Selected Gene Mutations to Resistance in Clinical Isolates of Vancomycin-Intermediate Staphylococcus aureus

(2012) Cory Hafer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis

(2012) S. J. van Hal et al.   CLINICAL INFECTIOUS DISEASES

Role of stop codons in development and loss of vancomycin non-susceptibility in methicillin-resistant Staphylococcus aureus

(2012) V. C. Doddangoudar et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Genetic Pathway in Acquisition and Loss of Vancomycin Resistance in a Methicillin Resistant Staphylococcus aureus (MRSA) Strain of Clonal Type USA300

(2012) Susana Gardete et al.   PLoS Pathogens

walKandclpPMutations Confer Reduced Vancomycin Susceptibility inStaphylococcus aureus

(2011) Mitsutaka Shoji et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vancomycin: We Can't Get There From Here

(2011) N. Patel et al.   CLINICAL INFECTIOUS DISEASES

Community-associated meticillin-resistant Staphylococcus aureus in children in Taiwan, 2000s

(2011) Yhu-Chering Huang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study

(2011) H.-J. Chang et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Impact of rpoB Mutations on Reduced Vancomycin Susceptibility in Staphylococcus aureus

(2011) Yukiko Watanabe et al.   JOURNAL OF CLINICAL MICROBIOLOGY

An RpoB Mutation Confers Dual Heteroresistance to Daptomycin and Vancomycin in Staphylococcus aureus

(2010) L. Cui et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fusidic Acid Resistance Determinants in Staphylococcus aureus Clinical Isolates

(2010) H.-J. Chen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications

(2010) B. P. Howden et al.   CLINICAL MICROBIOLOGY REVIEWS

Contribution of vraSR and graSR Point Mutations to Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus

(2009) L. Cui et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Selection of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus by Imipenem

(2009) Y. Katayama et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular and Phenotypic Characteristics of Methicillin-Resistant and Vancomycin-Intermediate Staphylococcus aureus Isolates from Patients with Septic Arthritis

(2009) W.-Y. Wang et al.   JOURNAL OF CLINICAL MICROBIOLOGY

SHRiMP: Accurate Mapping of Short Color-space Reads

(2009) Stephen M. Rumble et al.   PLoS Computational Biology

Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin

(2008) T. P. Lodise et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Genomic Analysis Reveals a Point Mutation in the Two-Component Sensor Gene graS That Leads to Intermediate Vancomycin Resistance in Clinical Staphylococcus aureus

(2008) B. P. Howden et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

agr function in clinical Staphylococcus aureus isolates

(2008) K. E. Traber et al.   MICROBIOLOGY-SGM